Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 2923018)

Published in Curr Opin HIV AIDS on July 01, 2010

Authors

Rebecca F Baggaley1, Christophe Fraser

Author Affiliations

1: Department of Infectious Disease Epidemiology, MRC Centre for Outbreak Analysis and Modelling, Imperial College London, London, UK. r.baggaley@imperial.ac.uk

Articles citing this

Universal testing and treatment as an HIV prevention strategy: research questions and methods. Curr HIV Res (2011) 2.60

Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One (2013) 1.79

Male circumcision for HIV prevention: current evidence and implementation in sub-Saharan Africa. J Int AIDS Soc (2011) 1.42

Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. Am J Public Health (2012) 1.34

Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review. Am J Public Health (2013) 0.90

Conceptual framework and research methods for migration and HIV transmission dynamics. AIDS Behav (2014) 0.84

Reconceptualizing the HIV epidemiology and prevention needs of Female Sex Workers (FSW) in Swaziland. PLoS One (2014) 0.80

Interaction of mathematical modeling and social and behavioral HIV/AIDS research. Curr Opin HIV AIDS (2011) 0.76

Acute HIV infection transmission among people who inject drugs in a mature epidemic setting. AIDS (2016) 0.75

Critical considerations for adopting the HIV 'treat all' approach in Zimbabwe: is the nation poised? Public Health Action (2016) 0.75

Reproductive justice & preventable deaths: state funding, family planning, abortion, and infant mortality, US 1980-2010. SSM Popul Health (2016) 0.75

How do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic review. Sex Transm Infect (2016) 0.75

Articles cited by this

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet (2006) 31.79

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS (2008) 13.25

Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med (2010) 12.08

Concurrent partnerships and the spread of HIV. AIDS (1997) 10.73

Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med (2007) 7.79

Integrating HIV prevention and treatment: from slogans to impact. PLoS Med (2005) 6.73

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

Effects of a behavioural intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomised controlled study. Lancet (2004) 5.57

A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52

Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86

Modelling HIV/AIDS epidemics in Botswana and India: impact of interventions to prevent transmission. Bull World Health Organ (2002) 4.47

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05

Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med (2009) 4.05

Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA (2004) 3.84

The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models. AIDS (2005) 3.71

Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Lancet Infect Dis (2002) 3.58

Concurrent partnerships and HIV prevalence disparities by race: linking science and public health practice. Am J Public Health (2009) 3.43

Progress and challenges in modelling country-level HIV/AIDS epidemics: the UNAIDS Estimation and Projection Package 2007. Sex Transm Infect (2008) 3.43

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38

Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32

Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med (2005) 2.84

Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti. Sex Transm Infect (2006) 2.65

Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS (2003) 2.60

Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52

Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS (2001) 2.48

SAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana. PLoS One (2007) 2.41

Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med (2001) 2.39

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS (2008) 2.25

No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS (2008) 2.04

The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam. AIDS (2003) 1.93

Primary HIV infection as source of HIV transmission within steady and casual partnerships among homosexual men. AIDS (2004) 1.82

Treating our way out of the HIV pandemic: could we, would we, should we? Lancet (2008) 1.78

The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol (2005) 1.76

Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. J Acquir Immune Defic Syndr (2006) 1.62

Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS (2010) 1.57

Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. BMC Public Health (2007) 1.57

Predicting the impact of antiretrovirals in resource-poor settings: preventing HIV infections whilst controlling drug resistance. Curr Drug Targets Infect Disord (2003) 1.55

Can antiretroviral therapy eliminate HIV transmission? Lancet (2008) 1.53

Predicting the epidemiological impact of antiretroviral allocation strategies in KwaZulu-Natal: the effect of the urban-rural divide. Proc Natl Acad Sci U S A (2006) 1.52

Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis (2004) 1.45

Will ART rollout in Africa drive an epidemic of drug resistant HIV? AIDS (2006) 1.42

An introduction to mathematical models in sexually transmitted disease epidemiology. Sex Transm Infect (2002) 1.40

Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol (2008) 1.31

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines. AIDS Rev (2003) 1.28

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.23

A model of the spread of HIV infection and the demographic impact of AIDS. Stat Med (1989) 1.22

Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS (2009) 1.11

Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options. Sex Transm Dis (2006) 1.10

Fitting the HIV epidemic in Zambia: a two-sex micro-simulation model. PLoS One (2009) 1.08

Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis (2003) 1.07

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.06

Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa? Trans R Soc Trop Med Hyg (2010) 1.05

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.05

The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?". PLoS One (2007) 1.04

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 1.04

Interpreting declines in HIV prevalence: impact of spatial aggregation and migration on expected declines in prevalence. Sex Transm Infect (2008) 1.02

Modeling trends in HIV incidence among homosexual men in Australia 1995-2006. J Acquir Immune Defic Syndr (2004) 1.00

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 0.99

The influence of different sexual-contact patterns between age classes on the predicted demographic impact of AIDS in developing countries. Ann N Y Acad Sci (1989) 0.95

Public health consequences of screening patients for adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 0.90

Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa. Sex Transm Infect (2008) 0.90

Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet (2009) 0.89

Modelling HIV incidence in gay men: increased treatment, unsafe sex and sexually transmissible infections. AIDS (2002) 0.85

A decrease in drug resistance levels of the HIV epidemic can be bad news. Bull Math Biol (2004) 0.85

HIV drug-resistant strains as epidemiologic sentinels. Emerg Infect Dis (2006) 0.82

Articles by these authors

Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92

Strategies for mitigating an influenza pandemic. Nature (2006) 25.20

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74

Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09

Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27

Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66

Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08

Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86

Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71

Fuzzy species among recombinogenic bacteria. BMC Biol (2005) 3.47

Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34

New strategies for the elimination of polio from India. Science (2006) 3.27

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18

West African Ebola epidemic after one year--slowing but not yet under control. N Engl J Med (2014) 2.96

Seasonal infectious disease epidemiology. Proc Biol Sci (2006) 2.62

Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science (2009) 2.54

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci (2004) 2.45

The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann Intern Med (2004) 2.36

Assessing the reliability of eBURST using simulated populations with known ancestry. BMC Microbiol (2007) 2.36

Mathematical models of infectious disease transmission. Nat Rev Microbiol (2008) 2.32

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS (2008) 2.25

Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17

The impact of homologous recombination on the generation of diversity in bacteria. J Theor Biol (2005) 1.99

HPTN 071 (PopART): rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment - a study protocol for a cluster randomised trial. Trials (2014) 1.94

A new framework and software to estimate time-varying reproduction numbers during epidemics. Am J Epidemiol (2013) 1.94

Sequences, sequence clusters and bacterial species. Philos Trans R Soc Lond B Biol Sci (2006) 1.91

Identifying currents in the gene pool for bacterial populations using an integrative approach. PLoS Comput Biol (2009) 1.89

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom. PLoS Curr (2009) 1.87

Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data. Epidemiology (2015) 1.83

Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med (2010) 1.83

HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics (2010) 1.72

HIV-1 transmitting couples have similar viral load set-points in Rakai, Uganda. PLoS Pathog (2010) 1.69

Modelling bacterial speciation. Philos Trans R Soc Lond B Biol Sci (2006) 1.55

Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis (2004) 1.43

New insights into the evolutionary rate of HIV-1 at the within-host and epidemiological levels. Proc Biol Sci (2012) 1.43

Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza. J R Soc Interface (2011) 1.40

Transmission characteristics of the 2009 H1N1 influenza pandemic: comparison of 8 Southern hemisphere countries. PLoS Pathog (2011) 1.38

No coexistence for free: neutral null models for multistrain pathogens. Epidemics (2008) 1.37

What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae? J R Soc Interface (2009) 1.30

27 years of the HIV epidemic amongst men having sex with men in the Netherlands: an in depth mathematical model-based analysis. Epidemics (2010) 1.26

Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS One (2012) 1.25

SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis (2004) 1.23

Within-host and between-host evolutionary rates across the HIV-1 genome. Retrovirology (2013) 1.21

Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One (2009) 1.20

The effectiveness of contact tracing in emerging epidemics. PLoS One (2006) 1.15

Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load. AIDS (2009) 1.11

Ebola Virus Disease among Male and Female Persons in West Africa. N Engl J Med (2016) 1.08

HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08

Integrating phylodynamics and epidemiology to estimate transmission diversity in viral epidemics. PLoS Comput Biol (2013) 1.07

How the dynamics and structure of sexual contact networks shape pathogen phylogenies. PLoS Comput Biol (2013) 1.05

Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest? J Acquir Immune Defic Syndr (2014) 1.03

The relationship between real-time and discrete-generation models of epidemic spread. Math Biosci (2008) 1.02

A strong case for viral genetic factors in HIV virulence. Viruses (2011) 1.01

The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (2014) 1.01

Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach. PLoS Comput Biol (2011) 0.97

Is HIV short-sighted? Insights from a multistrain nested model. Evolution (2013) 0.96

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions. PLoS Curr (2009) 0.95

Has the rate of CD4 cell count decline before initiation of antiretroviral therapy changed over the course of the Dutch HIV epidemic among MSM? PLoS One (2013) 0.95

After Ebola in West Africa--Unpredictable Risks, Preventable Epidemics. N Engl J Med (2016) 0.94

Phylodynamic inference and model assessment with approximate bayesian computation: influenza as a case study. PLoS Comput Biol (2012) 0.94

Inferring pandemic growth rates from sequence data. J R Soc Interface (2012) 0.93

Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. AIDS (2012) 0.91

Historical zoonoses and other changes in host tropism of Staphylococcus aureus, identified by phylogenetic analysis of a population dataset. PLoS One (2013) 0.90

The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databases. Am J Epidemiol (2006) 0.87

Epidemic growth rate and household reproduction number in communities of households, schools and workplaces. J Math Biol (2010) 0.87

How effectively can HIV phylogenies be used to measure heritability? Evol Med Public Health (2013) 0.85

Comparative potency of three antiretroviral therapy regimes in primary HIV infection. AIDS (2006) 0.85

Viral replication under combination antiretroviral therapy: a comparison of four different regimens. J Acquir Immune Defic Syndr (2002) 0.84

Interpretation of correlations in setpoint viral load in transmitting couples. AIDS (2010) 0.84

Genomic analysis of emerging pathogens: methods, application and future trends. Genome Biol (2014) 0.82

CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time. AIDS (2015) 0.78

Optimizing the precision of case fatality ratio estimates under the surveillance pyramid approach. Am J Epidemiol (2014) 0.77

Let it be sexual--selection, aggregation and distortion used to construct a case against sexual transmission. Int J STD AIDS (2003) 0.76

Correction: Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. PLoS Biol (2017) 0.75